A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALIC
about
Patient healthcare trajectory. An essential monitoring tool: a systematic review.Controversies in the management of cancer-associated thrombosis."I didn't really understand it, I just thought it'd help": exploring the motivations, understandings and experiences of patients with advanced lung cancer participating in a non-placebo clinical IMP trial.Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis.Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study
P2860
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALIC
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A feasibility study to inform ...... er-Associated Thrombosis (ALIC
@en
type
label
A feasibility study to inform ...... er-Associated Thrombosis (ALIC
@en
prefLabel
A feasibility study to inform ...... er-Associated Thrombosis (ALIC
@en
P2093
P50
P921
P356
P1476
A feasibility study to inform ...... er-Associated Thrombosis (ALIC
@en
P2093
Ander Cohen
Anthony Maraveyas
David Fitzmaurice
Hayley Prout
Jessica Baillie
Joanna Canham
Joanna D Smith
Kate Fletcher
Marie-Jet Bekkers
P304
vii-xxiii, 1-93
P356
10.3310/HTA19830
P50
P577
2015-10-01T00:00:00Z